FDA Approves Osteoporosis Injection
Caveat Emptor, these are the same clowns that approved Boniva and Fosamax, which cause bone deterioration.
~ Uncle Russ
The U.S. Food and Drug Administration today approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.
Osteoporosis is a disease that makes bones weak and more likely to break. About 80 percent of U.S. osteoporosis sufferers are women, though men do get osteoporosis. About half of women over age 50 will break a bone in their lifetime due to osteoporosis, according to the FDA.